At-Home Testing Market: COVID-19 Trends and Future Potential
This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
$$ 2999.00
This report At-Home Testing: COVID-19 Trends and Future Potential provides an overview of trends and developments in the home testing industry for the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The report covers trends and issues concerning:
Government support for COVID-19 home tests
COVID-19 home test sample types
COVID-19 home test modalities
OTC and DTC trends in COVID-19 testing
In addition to the various aforementioned trends, tests, and technologies covered in the report, At-Home Testing: COVID-19 Trends and Future Potential profiles several companies active in this market, including:
Abbott Laboratories
Becton Dickinson & Company (BD)
bioMérieux / BioFire Diagnostics
Cepheid, A Danaher Company
Fluidigm Corporation
GenMark Diagnostics, Inc., A Roche Diagnostics Company
LetsGetChecked/PrivaPath Diagnostics Limited
Lucira Health
LumiraDx
Mesa Biotech
OraSure Technologies, Inc.
QIAGEN N.V.
Quidel Corporation
Roche Diagnostics
Sherlock Biosciences
Siemens Healthineers
RELATED PRODUCTS
This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present.
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Covid-19 Vaccine Market Report The global COVID-19 vaccine market by revenue is expected to reach a value of USD 5 billion during 2021-2024.
Wholesale Global Market Report 2021: COVID-19 Impact and Recovery to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global wholesale market as it emerges from the COVID-19 shut down.
The global market for COVID-19 diagnostic services is valued at $60.3 billion in 2020. The market should grow from $84.4 billion in 2021 to $195.1 billion by 2027, at a compound annual growth rate (CAGR) of 15.0% during 2021-2027.